Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

29.27
Delayed Data
As of Aug 23
 -0.57 / -1.91%
Today’s Change
18.52
Today|||52-Week Range
53.39
-2.92%
Year-to-Date
What Zika Virus in Florida Means (and Doesn't Mean) for Intrexon
Aug 19 / MotleyFool.com - Paid Partner Content
Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase
Aug 10 / Zacks.com - Paid Partner Content
The Emperor Has No Clothes
Aug 17 / GuruFocus News - Paid Partner Content
Intrexon's Revenue Grows 17%. Here's Why Investors Should Be Worried.
Aug 10 / MotleyFool.com - Paid Partner Content
Why ZIOPHARM Oncology's Stock Broke Down in July
Aug 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close29.84
Today’s open29.90
Day’s range29.12 - 30.47
Volume1,173,744
Average volume (3 months)1,925,836
Market cap$3.5B
Dividend yield--
Data as of 4:01pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-88.60%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...-0.04-0.12%
CTLTCatalent Inc+0.83+3.36%
TECHBio-Techne Corp-0.56-0.52%
KITEKite Pharma Inc-0.90-1.47%
Data as of 4:00pm ET, 08/23/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers

Search for Jobs